[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369479-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369479-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dna-methylation-signatures-of-cervical-pre-invasive-and-invasive-disease-an-epigenome-wide-association-study","DNA methylation signatures of cervical pre-invasive and invasive disease - An epigenome-wide association study","","Epigenetic alterations are key in cancer development, yet epigenome-wide profiling in cervical cancer has been limited. This epigenome-wide association study (EWAS) analyzes differential DNA methylation associated with CIN grade 3 and cervical cancer to identify potential drivers and biomarkers. Data from 247 women recruited between 2014 and 2020 were generated using Illumina 850k arrays on exfoliated cervical cells, then modeled with logistic regression and conditional analyses adjusting for batch, chip, age, and HPV status.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dna-methylation-signatures-of-cervical-pre-invasive-and-invasive-disease-an-epigenome-wide-association-study/369479/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dna-methylation-signatures-of-cervical-pre-invasive-and-invasive-disease-an-epigenome-wide-association-study/369479.png","ImageObject",300,407,{"name":42,"@type":43},"Maya Linwood","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the EWAS address in cervical cancer?","Question",{"text":63,"@type":64},"It explores differential DNA methylation signatures linked to CIN grade 3 and cervical cancer to uncover potential drivers and biomarkers of cervical carcinogenesis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were DNA methylation measurements generated and analyzed?",{"text":68,"@type":64},"Methylation signatures were obtained from exfoliated cervical cells and sequenced using the Illumina 850k EPIC methylation array, with logistic regression and conditional analyses testing CpG sites while adjusting for batch, chip, age, and HPV status.",{"name":70,"@type":61,"acceptedAnswer":71},"Which methylation markers were identified as independent biomarkers?",{"text":72,"@type":64},"Conditional analysis highlighted two independently associated CpG sites in PAX1 (cg16767801) and NREP-AS1 (cg23642047), and their combined signal showed strong performance for detecting CIN3 or worse.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369479,1790636183,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","DOI: 10.1002/ijc.35406  \nRES EARCH A RTICLE  \nC a ncer Geneti cs an d E p igen e ti cs  \nDNA methylation signatures of cervical pre-invasive  \nand invasive disease: An epigenome-wide association study  \nSarah J. Bowden 1,2,3 | Barbara Bodinier 4 | Maria Paraskevaidi 1 | Ilkka Kalliala 1,5 | Maria Nasioutziki 6 | Laura Burney Ellis 1,2,3 | Ruben Colindres Zuehlke 4 |  \nJames M. Flanagan 2 | Maria Kyrgiou 1,2,3  | Marc Chadeau-Hyam 4  \n1Department of Metabolism, Digestion and Reproduction, IRDB, Faculty of Medicine, Imperial College London, London, UK 2Department of Surgery & Cancer, IRDB, Faculty of Medicine, Imperial College London, London, UK  \n3West London Gynaecology Cancer Centre, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, UK 4Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK 5Department of Obstetrics & Gynaecology, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland  \n6Molecular Cytopathology Laboratory 2nd Obstetrics & Gynecology Clinic, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece  \nCorrespondence  \nMaria Kyrgiou, 3rd Floor IRDB, Hammersmith Hospital Campus, Imperial College London, Du Cane Road, W12 0HS, London. [Email:](Email: m.kyrgiou@imperial.ac.uk)[ m.kyrgiou@imperial.ac.uk](Email: m.kyrgiou@imperial.ac.uk)  \nMarc Chadeau-Hyam, School of Public Health, Department of Epidemiology and Biostatistics, Imperial College London, St Mary's Hospital, Norfolk Place W21PG, London. [Email:](Email: m.chadeau@imperial.ac.uk)[ m.chadeau@imperial.ac.uk](Email: m.chadeau@imperial.ac.uk)  \nFunding information  \nHorizon 2020 Framework Programme, Grant/Award Numbers: 874627, 874739; Cancer Research UK, Grant/Award Numbers:  \n22184, P92114; Imperial Health Charity, Grant/Award Numbers: P73337, RFPR2223 _ 27; Wellcome Trust, Grant/Award Number: P77712; NIHR Imperial Biomedical Research Centre, Grant/Award Number:  \nP77712  \nAbstract  \nEpigenetic alterations are essential in the development of cancers, while epigenomewide exploration in cervical cancer has been limited. In this epigenome-wide association study (EWAS) we explore differential DNA methylation signatures associated with CIN (cervical intraepithelial neoplasia) grade 3 and cervical cancer to better understand potential drivers and biomarkers of cervical carcinogenesis. 247 women were recruited between 2014 and 2020 (N = 119 benign, N = 74 CIN3/CGIN [cervical glandular intraepithelial neoplasia] and N = 54 cancer) . Methylation signatures were obtained from exfoliated cervical cells and sequenced using the Illumina 850 k array. Logistic regression and conditional analyses were used to test for independent associations between Cytosine-phosphate-Guanine (CpG) sites and case–control status, with adjustment for batch, chip, age, and human papillomavirus (HPV) status.  \n409 CpG sites were strongly associated with CIN3/cancer (p-value \u003C5 􀀁 10􀀃8) . Following conditional analysis, two CpG sites located in PAX1 (cg16767801) and NREPAS1 genes (cg23642047) were independently associated with case status, yielding an area under the curve (AUC) of 0 .92 (AUC = 0.97 for invasive disease) . In a validation dataset (CIN3 only) PAX1/NREP-AS1 yielded a combined AUC of 0 .77. Methylation markers offer promise for use in cervical screening, particularly as triage tests and self-sampling. We have identified a novel combined methylation marker that offers a high accuracy for the detection of CIN3 or worse.  \nJames M. Flanagan, Maria Kyrgiou, and Marc Chadeau-Hyam are joint senior investigators.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s) . International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.  \nKEYWOR DS  \ncervical cancer, cervical intraepitheli","cbCait3jksLnlpsd","https://ap.wps.com/l/cbCait3jksLnlpsd","pdf",3255105,12,"English","# Abstract\n# What's New?\n# Introduction","[{\"question\":\"What question does the EWAS address in cervical cancer?\",\"answer\":\"It explores differential DNA methylation signatures linked to CIN grade 3 and cervical cancer to uncover potential drivers and biomarkers of cervical carcinogenesis.\"},{\"question\":\"How were DNA methylation measurements generated and analyzed?\",\"answer\":\"Methylation signatures were obtained from exfoliated cervical cells and sequenced using the Illumina 850k EPIC methylation array, with logistic regression and conditional analyses testing CpG sites while adjusting for batch, chip, age, and HPV status.\"},{\"question\":\"Which methylation markers were identified as independent biomarkers?\",\"answer\":\"Conditional analysis highlighted two independently associated CpG sites in PAX1 (cg16767801) and NREP-AS1 (cg23642047), and their combined signal showed strong performance for detecting CIN3 or worse.\"}]","DNA methylation signatures of cervical pre-invasive and invasive disease - An epigenome-wide association study | PDF",1790182916,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c24cbbfab8415c99d5c717126a9fcd4.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1a983968ffcd51bad2943f35001c181.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37a5307a594dd088c84beab3d53e0149.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1818917b5eef0f7b8e2f91c4eb6d726.webp",980,1287]